Hepatoprotective effect of matrine salvianolic acid b salt on carbon tetrachloride-induced hepatic fibrosis

Journal of Inflammation (United Kingdom)

Volumn 9, Issue 1, 2012, Pages

  Gao, Hong Ying ^a,b   Li, Guo Yu ^a,c   Lou, Meng Meng ^a   Li, Xiao Yu ^a   Wei, Xiu Yan ^b   Wang, Jin Hui ^a,b,c  

^a SHIHEZI UNIVERSITY   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^c Key Laboratory of Phytomedicine Resources and Modernization of TCM   (China)

Author keywords

Carbon tetrachloride; Hepatic fibrosis; Matrine salvianolic acid B salt

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA SMOOTH MUSCLE ACTIN; ANTIFIBROTIC AGENT; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; EOSIN; FATTY ACID DERIVATIVE; GLUTATHIONE; HEMATOXYLIN; HEXADECENOIC ACID; HYDROXYPROLINE; LAMININ; LIVER PROTECTIVE AGENT; MALONALDEHYDE; MATRINE; MATRINE SALVIANOLIC ACID B SALT; SALVIANOLIC ACID B; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINO ACID BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CARBON TETRACHLORIDE-INDUCED LIVER FIBROSIS; CONTROLLED STUDY; DEPLETION; ENZYME BLOOD LEVEL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; LIVER PROTECTION; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SALVIA MILTIORRHIZA; SOPHORA FLAVESCENS; STAINING;

EID: 84860539736     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-9-16     Document Type: Article

References (26)

1. Albanis E, Friedman SL: Hepatic fibrosis. Pathogenesis and principles of therapy. J Clin Liver Dis 2001, 5: 315-334.
2. Ibrahim HB, Suleyman SK, Orhan KP, Mehmet Y, Ibrahim HO, Bilal U, Ahmet I: Hepatoprotective effect of Infliximab, an Anti-TNF-A Agent, on Carbon Tetrachloride-Induced Hepatic Fibrosis. Inflammation 2008, 31: 215-221.
3. Lamireau T, Desmouliere A, Bioulac-Sage P: Mechanisms of hepatic fibrogenesis. J Arch Pediatr 2002, 9: 392-405.
4. Recknagel R, Glende EA, Dolak JA, Waller RL: Mechanisms of carbon tetrachloride toxicity. Pharma Ther 1989, 43: 139-154.
5. Brattin WJ, Glende EA, Recknagel RO: Pathological mechanisms in carbon tetrachloride hepatotoxicity. J Free Radic Biol Med 1985, 1: 27-28.
6. Nadkarni GD, D'Souza NB: Hepatic antioxidant enzymes and lipid peroxidation in carbon tetrachloride-induced liver cirrhosis in rats. Biochem Med Metabol Biol 1988, 40: 42-45.
7. Gassó M, Rubio M, Varela G, Cabré M, Caballería J, Alonso E, Deulofem R, Camps J, Giménez A, Pajares M, Parés A, Mato JM, Rodés J: Effects of Sadenosylmethionine on lipid peroxidation and liver fibrogenesis in carbon tetrachloride-induced cirrhosis. J Hepatol 1996, 25: 200-205.
8. Jung Y, Wan X, Yan H, Row K: Determination of matrine and oxymatrine in Sophora flavescens ait. Via high performance liquid chromatography. J Liq Chromatogr Related Technol 2008, 31: 2752-2761.
9. Hong M, Lee J, Jung H, Jin D, Go H, Kim J, Jang B, Shin Y, Ko S: Sophora flavescens ait. on inhibits the production of pro-inflammatory cytokines through inhibition of the NF jB/IjB signal pathway in human mast cell line (HMC-1). Toxicol Vitr 2009, 23: 251-258.
10. Cheng H, Xia B, Zhang L, Zhou F, Zhang YX, Ye M, Hu ZG, Li J, Li J, Wang ZL, Li C, Guo QS: Matrine improves 2,4,6-trinitrobenzene sulfonic acidinduced colitis in mice. Pharmacol Res 2006, 53: 202-208.
11. Ma L, Wen S, Zhan Y, He Y, Liu X, Jiang J: Anticancer effects of the chinese medicine matrine on murine hepatocellular carcinoma cells. Planta Med 2008, 74: 245-251.
12. Zhang JP, Zhang M, Jin C, Zhou B, Xie WF, Guo C: Matrine inhibits production and actions of fibrogenic cytokines released by mouse peritoneal macrophages. Acta Pharmacol Sin 2001, 22: 765-768.
13. Zhou L, Zuo Z, Chow MSS: Danshen: An overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol 2005, 45: 1345-1359.
14. Tsai MK, Lin YL, Huang YT: Effects of salvianolic acids on oxidative stress and hepatic fibrosis in rats. Toxicol Appl Pharmacol 2010, 242: 155-164.
15. Zhang J: Inhibitory Action of Salvianolic Acid B on the Contraction of Hepatic Stellate Cells Induced by Endothelin and its Mechanism. Shanghai: Shanghai University of Traditional Chinese Medicine, Chinese; 2004.
16. Gao HY, Li GY, Wang HY, Wang JH: Structure identification of Matrine Salvianolic acid B salt. Mod Chin Med 2010, 12: 22-25.
17. Ruwart MJ, Wilkinson KF, Rush BD: The integrated value of serum procollagen III peptide over time predicts hepatic hydroxyproline content and stainable collagen in a model of dietary cirrhosis in the rat. Hepatology 1989, 10: 801-806.
18. Tsai CF, Hsu YW, Chen WK, Chang WH, Yen CC, Ho YC, Lu FJ: Hepatoprotective effect of electrolyzed reduced water against carbon tetrachloride-induced liver damage in mice. Food Chem Toxicol 2009, 47: 2031-2036.
19. Li J, Niu JZ, Zeng Y: Effects of FFBJRGP on collagen deposition in hepatic Disse space in alcohol induced liver fibrosis in rat. Med J Chin PLA 2004, 29: 567-570.
20. Friedman SL: Liver fibrosis from bench to bedside. J Hepatol 2003, 38: S38-S53.
21. Nyberg A, Anna EL, Loof L: Serum hyaluronate in primary biliary cirrhosis: A biochemical marker for progrewssive liver damage. Hepatology 1988, 8: 142-146.
22. Koca SS, Bahcecioglu IH, Poyrazoglu OK, Ozercan IH, Sahin K, Ustundag B: The treatment with antibody of TNF-alpha reduces the inflammation, necrosis and fibrosis in the non-alcoholic steatohepatitis induced by methionine and cholinedeficient diet. Inflammation 2007, 31: 91-98.
23. Freedman AR, Sharma RJ, Nabel GJ, Emerson SG, Griffin GE: Cellular distribution of nuclear factor kappa B binding activity in rat liver. Biochem J 1992, 287: 645-649.
24. Tilg H: The role of cytokines in the pathophysiology of chronic liver diseases. Int J Clin Lab Res 1993, 23: 179-185.
25. Gurujeyalakshmi G, Giri SN: Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: Down regulation of TGF-beta and procollagen I and III gene expression. Exp Lung Res 1995, 21: 791-808.
26. Kimura K, Ando K, Ohnishi H, Ishikawa T, Kakumu S, Takemura M, Muto Y, Moriwaki H: Immunopathogenesis of hepatic fibrosis in chronic liver injury induced by repeatedly administered concanavalin A. Int Immunol 1999, 11: 1491-1500.